Medindia

X

Fujifilm to Buy US Vaccine Maker

by Bidita Debnath on  October 27, 2014 at 10:48 PM General Health News   - G J E 4
As Fujifilm boosts its supply of an experimental Ebola drug to help stem the spread of the virus, the Japanese firm said that it would buy a US vaccine maker.
 Fujifilm to Buy US Vaccine Maker
Fujifilm to Buy US Vaccine Maker
Advertisement

The deal would see Fujifilm take a 49 percent stake in Kalon Biotherapeutics, with plans to buy the whole company "in the future", the company said, without supplying financial details.

Advertisement
Japan's leading Nikkei business daily said the acquisition would be worth several billion yen (tens of millions of dollars).

Kalon, established in 2011 by the State of Texas and Texas A&M University as a contract maker of biopharmaceutical products, can safely handle and produce vaccines against deadly pathogens, including anthrax, Fujifilm said, as it looks to further tap the health sector.

The firm's shares jumped 2.88 percent to 3,691.0 yen in Tokyo on Monday.

Fujifilm said last week it would increase its stock of Avigan, which has been given to several patients who were evacuated from Ebola-hit West Africa to Europe.

The firm said it has enough Avigan tablets -- approved as an influenza drug in Japan -- to treat 20,000 people and enough of its active ingredient for 300,000 treatments.

Some research papers report that Avigan has been effective in testing with mice, the company said.

The governments of France and Guinea are planning to conduct clinical trials with Avigan in mid-November.

Like some other major Japanese firms, Fujifilm, once among the biggest makers of camera film, has been transitioning into new sectors as it traditional business suffers.

Source: AFP
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All